J. Lyle Bootman

1.4k total citations
52 papers, 1.1k citations indexed

About

J. Lyle Bootman is a scholar working on Geriatrics and Gerontology, Economics and Econometrics and General Health Professions. According to data from OpenAlex, J. Lyle Bootman has authored 52 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Geriatrics and Gerontology, 14 papers in Economics and Econometrics and 11 papers in General Health Professions. Recurrent topics in J. Lyle Bootman's work include Pharmaceutical Practices and Patient Outcomes (19 papers), Health Systems, Economic Evaluations, Quality of Life (12 papers) and Pharmaceutical Economics and Policy (8 papers). J. Lyle Bootman is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (19 papers), Health Systems, Economic Evaluations, Quality of Life (12 papers) and Pharmaceutical Economics and Policy (8 papers). J. Lyle Bootman collaborates with scholars based in United States, Canada and United Kingdom. J. Lyle Bootman's co-authors include Jeffrey Johnson, William F. McGhan, Raymond J. Townsend, Albert I. Wertheimer, Clayton Rowland, Darwin E. Zaske, Lon N. Larson, Linda MacKeigan, JoLaine R. Draugalis and Clayton R. Rowland and has published in prestigious journals such as The American Journal of Medicine, Journal of the American Geriatrics Society and Journal of Pharmaceutical Sciences.

In The Last Decade

J. Lyle Bootman

49 papers receiving 962 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Lyle Bootman United States	13	516	362	191	151	149	52	1.1k
Patrick D. Meek United States	13	646 1.3×	252 0.7×	240 1.3×	240 1.6×	152 1.0×	30	1.2k
Soraya Dhillon United Kingdom	15	610 1.2×	241 0.7×	212 1.1×	215 1.4×	199 1.3×	30	979
Robert L. Maher United States	7	954 1.8×	475 1.3×	165 0.9×	80 0.5×	144 1.0×	13	1.4k
Niels Damsbo Denmark	15	513 1.0×	132 0.4×	333 1.7×	199 1.3×	103 0.7×	25	956
Anne Gerd Granås Norway	20	595 1.2×	286 0.8×	364 1.9×	157 1.0×	206 1.4×	61	1.2k
David W. Bates United States	5	422 0.8×	149 0.4×	145 0.8×	273 1.8×	254 1.7×	11	915
A.W. Lenderink Netherlands	14	458 0.9×	109 0.3×	178 0.9×	318 2.1×	65 0.4×	20	1.2k
Anders Carlsten Sweden	19	316 0.6×	384 1.1×	221 1.2×	35 0.2×	97 0.7×	30	922
Anna Birna Almarsdóttir Denmark	19	518 1.0×	309 0.9×	331 1.7×	136 0.9×	262 1.8×	79	1.5k
John D. Barratt Australia	18	661 1.3×	357 1.0×	108 0.6×	86 0.6×	249 1.7×	34	1.3k

Countries citing papers authored by J. Lyle Bootman

Since Specialization

Citations

This map shows the geographic impact of J. Lyle Bootman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Lyle Bootman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Lyle Bootman more than expected).

Fields of papers citing papers by J. Lyle Bootman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Lyle Bootman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Lyle Bootman. The network helps show where J. Lyle Bootman may publish in the future.

Co-authorship network of co-authors of J. Lyle Bootman

This figure shows the co-authorship network connecting the top 25 collaborators of J. Lyle Bootman. A scholar is included among the top collaborators of J. Lyle Bootman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Lyle Bootman. J. Lyle Bootman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bootman, J. Lyle, Cynthia J. Boyle, Patricia A. Chase, et al.. (2018). Vital Directions for Pharmacy Education and Practice: Report of the 2017-18 Argus Commission. American Journal of Pharmaceutical Education. 82(7). 7161–7161. 1 indexed citations

Baldwin, Jeffrey N., et al.. (2015). Pharmacy Practice, Education, and Research in the Era of Big Data: 2014-15 Argus Commission Report. American Journal of Pharmaceutical Education. 79(10). S26–S26. 10 indexed citations

Bootman, J. Lyle. (2006). Value in health care.. PubMed. 19(7). 24, 27–24, 27. 2 indexed citations

Bootman, J. Lyle, William H. Crown, & Allan T. Luskin. (2004). Clinical and economic effects of suboptimally controlled asthma.. PubMed. 17(1). 31–6. 12 indexed citations

Hakim, Zafar, et al.. (1999). The Economics of Multiple Sclerosis. PharmacoEconomics. 15(3). 229–240. 36 indexed citations

Bootman, J. Lyle. (1997). The Health Care Cost of Drug-Related Morbidity and Mortality in Nursing Facilities. Archives of Internal Medicine. 157(18). 2089–2089. 211 indexed citations

Bootman, J. Lyle & Richard Milne. (1996). Costs, Innovation and Efficiency in Anti-Infective Therapy. PharmacoEconomics. 9(Supplement 1). 31–39. 4 indexed citations

Moore, Keith A., et al.. (1993). Change in Prescribing Patterns of Intravenous Histamine₂-Receptor Antagonists Results in Significant Cost Savings without Adversely Affecting Patient Care. Annals of Pharmacotherapy. 27(2). 232–237. 8 indexed citations

MacKeigan, Linda, et al.. (1993). Time Preference for Health Gains Versus Health Losses. PharmacoEconomics. 3(5). 374–386. 55 indexed citations

10.

McGhan, William F., J. Lyle Bootman, Raymond J. Townsend, et al.. (1991). Evaluation of Direct Pharmacist Intervention on Conversion from Parenteral to Oral Histamine H₂-Receptor Antagonist Therapy. DICP. 25(1). 80–84. 8 indexed citations

11.

Hurd, Peter D., et al.. (1989). The effects of aging and diabetes on the perception of medication color. 4(2). 113–121. 3 indexed citations

12.

Einarson, Thomas R., et al.. (1989). Demand for a blood level testing service in an ambulatory geriatric population. 3(4). 109–123. 1 indexed citations

13.

MacKeigan, Linda & J. Lyle Bootman. (1988). A Review of Cost-Benefit and Cost-Effectiveness Analyses of Clinical Pharmacy Services. Journal of Pharmaceutical Marketing & Management. 2(3). 63–84. 12 indexed citations

14.

Bootman, J. Lyle. (1987). Chair Report for the Academic Affairs Committee. American Journal of Pharmaceutical Education. 51(4). 451–454. 1 indexed citations

15.

Bootman, J. Lyle. (1986). Application of cost-benefit analysis to community pharmacy practice. 119(6). 295–303. 1 indexed citations

16.

Bootman, J. Lyle, et al.. (1984). An Assessment of Learning Styles Among Pharmacy Students. American Journal of Pharmaceutical Education. 48(2). 134–140. 26 indexed citations

17.

Bootman, J. Lyle, et al.. (1984). Diffusion of innovation: computer technology in hospital pharmacy.. PubMed. 41(11). 2343–7. 1 indexed citations

18.

Bootman, J. Lyle, et al.. (1980). Demographic Characteristics of Elderly Drug Overdose Patients Admitted to a Hospital Emergency Department. Journal of the American Geriatrics Society. 28(12). 544–546. 8 indexed citations

19.

Bootman, J. Lyle, Darwin E. Zaske, Albert I. Wertheimer, & Clayton Rowland. (1979). Cost of individualizing aminoglycoside dosage regimens. American Journal of Health-System Pharmacy. 36(3). 368–370. 12 indexed citations

20.

McGhan, William F., Clayton R. Rowland, & J. Lyle Bootman. (1978). Cost-benefit and cost-effectiveness: Methodologies for evaluating innovative pharmaceutical services. American Journal of Health-System Pharmacy. 35(2). 133–140. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact